Correlation Between GlaxoSmithKline PLC and Fuller Thaler
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Fuller Thaler at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Fuller Thaler into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Fuller Thaler Behavioral, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Fuller Thaler and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Fuller Thaler. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Fuller Thaler.
Diversification Opportunities for GlaxoSmithKline PLC and Fuller Thaler
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Fuller is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Fuller Thaler Behavioral in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fuller Thaler Behavioral and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Fuller Thaler. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fuller Thaler Behavioral has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Fuller Thaler go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Fuller Thaler
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 9.73 times less return on investment than Fuller Thaler. In addition to that, GlaxoSmithKline PLC is 1.16 times more volatile than Fuller Thaler Behavioral. It trades about 0.01 of its total potential returns per unit of risk. Fuller Thaler Behavioral is currently generating about 0.08 per unit of volatility. If you would invest 3,508 in Fuller Thaler Behavioral on August 29, 2024 and sell it today you would earn a total of 1,748 from holding Fuller Thaler Behavioral or generate 49.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Fuller Thaler Behavioral
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Fuller Thaler Behavioral |
GlaxoSmithKline PLC and Fuller Thaler Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Fuller Thaler
The main advantage of trading using opposite GlaxoSmithKline PLC and Fuller Thaler positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Fuller Thaler can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fuller Thaler will offset losses from the drop in Fuller Thaler's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Fuller Thaler vs. Fuller Thaler Behavioral | Fuller Thaler vs. Fuller Thaler Behavioral | Fuller Thaler vs. Fuller Thaler Behavioral |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |